Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women

[11] Faraj K.H.(1991)Influence of menstrual cycle and gender on alprazolam pharmacokinetics Clin Pharmacol Ther 50 404-9

[12] Lew E.A.(1995)Do alcohol pharmacokinetics in women vary due to the menstrual cycle Addiction 90 23-30

[13] Ludwig M.A.(2001)Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women Clin Drug Invest 21 715-26

[14] Milad J.D.(1997)Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy New Engl J Med 337 734-9

[15] Lane J.F.(1999)A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy J Infect Dis 180 659-65

[16] Steege S.L.(1996)A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir) AIDS 10 485-92

[17] Rupp K.L.(1998)Single-dose pharmacokinetics of indinavir and the effect of food Antimicrob Agents Chemother 42 332-8

[18] Austin L.E.(1999)Indinavir concentrations and antiviral effect Pharmacotherapy 19 708-12

[19] Mather C.R.(1996)Sex-dependent pharmacokinetics of indinavir in vivo and in vitro evidence Drug Metab Dispos 24 1298-306

[20] Philpot C.M.(1995)Metabolites of L-735, 524, a potent HIV-1 protease inhibitor, in human urine Drug Metab Dispos 23 266-70

[11] Faraj K.H.(1991)Influence of menstrual cycle and gender on alprazolam pharmacokinetics Clin Pharmacol Ther 50 404-9

[12] Lew E.A.(1995)Do alcohol pharmacokinetics in women vary due to the menstrual cycle Addiction 90 23-30

[13] Ludwig M.A.(2001)Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women Clin Drug Invest 21 715-26

[14] Milad J.D.(1997)Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy New Engl J Med 337 734-9

[15] Lane J.F.(1999)A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy J Infect Dis 180 659-65

[16] Steege S.L.(1996)A 24-week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir) AIDS 10 485-92

[17] Rupp K.L.(1998)Single-dose pharmacokinetics of indinavir and the effect of food Antimicrob Agents Chemother 42 332-8

[18] Austin L.E.(1999)Indinavir concentrations and antiviral effect Pharmacotherapy 19 708-12

[19] Mather C.R.(1996)Sex-dependent pharmacokinetics of indinavir in vivo and in vitro evidence Drug Metab Dispos 24 1298-306

[20] Philpot C.M.(1995)Metabolites of L-735, 524, a potent HIV-1 protease inhibitor, in human urine Drug Metab Dispos 23 266-70